MedPath

Multi-institutional collaborative study on antigen-positive red blood cells (RBCs) transfusion for the patients who have corresponding irregular RBC antibodies

Not Applicable
Recruiting
Conditions
Patients having RBC irregular antibodies and received corresponding antigen-positive RBC transfusion
Registration Number
JPRN-UMIN000037218
Lead Sponsor
Japan Erythrocyte Irregular Antibody Study Group
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
1000
Inclusion Criteria

Not provided

Exclusion Criteria

Cases without any of the above mentioned criteria.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Back grounds of patients, Ags on RBCs transfused, total amounts of Ag-positive RBCs transfusion, results from screening and direct anti-globulin test (DAT), specificity of Abs, adverse reactions and efficacies.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath